Stand Up To Cancer is supporting a translational research team to explore how chimeric antigen receptor T-cell therapy, which has been applied in blood cancers, can be applied to pancreatic cancer, the American Association for Cancer Research, SU2C’s Scientific Partner, announced.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
